This new investment will further power Enveda's data-driven approach to screening, validating, and developing high-potential natural compounds into first-in-class clinical candidates.

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1880 S Flatiron Ct. K
Boulder, CO 80301
USA

Phone

(415) 323-5252

Website

www.envedabio.com

Email Address

[email protected]

Overview

At Enveda, we're harnessing the complexity of the natural world to tackle today's biggest healthcare challenges. With the help of breakthrough advancements in knowledge graphs, machine learning, and metabolomics, we're discovering the next generation of small molecules.

Profile

Social Media

Enveda Biosciences Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Viswa Colluru

Chief Scientific Officer

Sotirios Karathanasis

Chief Technical Officer

Joseph Rokicki

Vice President

David Healey

Vice President

Bryan Norman

VP - Administration

Daniel Wee

VP - Engineering

Chris Diana

VP - Product Management

Hannah Gordon

Browse more venture capital transactions:

Prev: 6/23/2021: G2 Crowd venture capital transaction
Next: 6/23/2021: Oyster venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary